Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hill-Rom beds subject of MHRA (Medicines and Healthcare products Regulatory Agency) alert:

This article was originally published in Clinica

Executive Summary

Hill-Rom, of Batesville, Indiana, is the subject of a device alert by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), following problems with its Evolution 150BO electric beds. On April 14, Hill-Rom announced restructuring plans thatwill see up to 300 salaried jobs from its current total of 6,100 cut over the next 12 months, while taking on some 100 sales staff. "The next phase of our strategy [is] greater emphasis on new revenue growth," said Frederick Rockwood, president and CEO of Hill-Rom's parent company, Hillenbrand Industries. Hill-Rom reported revenues of $1.2bn in the year to September 30 2002. "The new structure will improve our ability to integrate possible future acquisitions," said Hill-Rom president and CEO R Ernest Waaser. Faults in devices fitted with an SKF head-end actuator have resulted in the bed being unable to adopt - even manually - the cardio-pulmonary resuscitation (CPR) position when the head-end electric motor is turned off. 3,445 such beds have been sold in the UK since June 2001. Hill-Rom claims to be aware of problems in a "small percentage of production", says the MHRA, but one UK National Health Service hospital reported that 11 of its 17 Evolution 150BOs were affected.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061857

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel